Author:
Beer H.-F.,Rossetti I.,Frey L.D.,Hasler P.H.,Schubiger P.A.
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine
Reference27 articles.
1. Large scale preparation strategy for labeling of 123I-SCH 23982, a dopamine D1 receptor binding agent;Beer;Appl. Rad. Isot.,1992
2. [123I18F] N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamides, site specific tracers for MAO-B mapping with SPET and PET;Beer,1994
3. [123I125I]Ro 43–0463, a site specific tracer for MAO-B mapping with autoradiography as well as with SPET;Beer;J. Recept. & Signal Transduct. Res.,1995
4. Comparison of two synthetic methods to obtain [18F] N-(2-aminoethyl)-5-fluoropyridine-2-carboxamide, a potential MAO-B imaging tracer for PET;Beer;J. Lab. Compd. Radiopharm.,1958
5. Measurement of human cerebral monoamine oxidase type R (MAO-B) activity with positron emission tomography (PET): A dose ranging study with the reversible inhibitor Ro 19–6327;Bench;Eur. J. Clin. Pharmacol.,1991
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献